Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635406 | SCV000756819 | pathogenic | Aniridia 1; Irido-corneo-trabecular dysgenesis | 2018-01-02 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 8-13 of the PAX6 gene. The 5' boundary is likely confined to intron 7. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. Gross deletions of exons 8-13 has been observed in individuals affected with aniridia (PMID: 18483559, Invitae). This deletion has been described in the literature as deletions of exons 9-14 based on alternative exon numbering. For these reasons, this variant has been classified as Pathogenic. |